Opening Recap Market Pulse: Asia’s chip consolidation scene rips into headlines as UTAC’s sale...
Archive - September 16, 2025
APGE Soars: BofA’s $87 Price Target After Trial Breakthrough!
Company Overview & Recent Breakthrough Apogee Therapeutics (NASDAQ: APGE) is a clinical-stage...